Vimpat
lacosamide
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What Vimpat is and what it is used for
What you need to know before you take Vimpat
How to take Vimpat
Possible side effects
How to store Vimpat
Contents of the pack and other information
Vimpat contains lacosamide. This belongs to a group of medicines called “antiepileptic medicines”.
These medicines are used to treat epilepsy.
You have been given this medicine to lower the number of fits (seizures) you have.
Vimpat is used:
on its own and in association with other antiepileptic medicines in adults, adolescents and children aged 2 years and older to treat a certain type of epilepsy characterised by the occurrence of partial-onset seizure with or without secondary generalisation. In this type of epilepsy, fits first affect only one side of your brain. However, these may then spread to larger areas on both sides of your brain;
in association with other antiepileptic medicines in adults, adolescents and children aged 4 years and older to treat primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in patients with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).
if you are allergic to lacosamide, or any of the other ingredients of this medicine (listed in section 6). If you are not sure whether you are allergic, please discuss with your doctor.
if you have a certain type of heart beat problem called second- or third-degree AV block.
Do not take Vimpat if any of the above applies to you. If you are not sure, talk to your doctor or
pharmacist before taking this medicine.
Talk to your doctor before taking Vimpat if:
you have thoughts of harming or killing yourself. A small number of people being treated with antiepileptic medicinal products such as lacosamide have had thoughts of harming or killing themselves. If you have any of these thoughts at any time, tell your doctor straight away.
you have a heart problem that affects the beat of your heart and you often have a particulary slow, fast or irregular heart beat (such as AV block, atrial fibrillation and atrial flutter).
you have severe heart disease such as heart failure or have had a heart attack.
you are often dizzy or fall over. Vimpat may make you dizzy - this could increase the risk of accidental injury or a fall. This means that you should take care until you are used to the effects of this medicine.
If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking Vimpat.
If you are taking Vimpat, talk to your doctor if you are experiencing a new type of seizure or
worsening of existing seizures.
If you are taking Vimpat and you are experiencing symptoms of abnormal heartbeat (such as slow, rapid or irregular heartbeat, palpitations, shortness of breath, feeling lightheaded, fainting), seek
medical advice immediately (see section 4).
Vimpat is not recommended for children aged under 2 years with epilepsy characterised by the
occurrence of partial-onset seizure and not recommended for children aged under 4 years with primary generalised tonic-clonic seizures. This is because we do not yet know whether it will work and
whether it is safe for children in this age group.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines that affect your heart - this is because Vimpat can also affect your heart:
medicines to treat heart problems;
medicines which can increase the “PR interval” on a scan of the heart (ECG or electrocardiogram) such as medicines for epilepsy or pain called carbamazepine, lamotrigine or pregabalin;
medicines used to treat certain types of irregular heart beat or heart failure.
If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking Vimpat.
Also tell your doctor or pharmacist if you are taking any of the following medicines - this is because they may increase or decrease the effect of Vimpat on your body:
medicines for fungal infections such as fluconazole, itraconazole or ketoconazole;
medicines for HIV such as ritonavir;
medicines used to treat bacterial infections such as clarithromycin or rifampicin;
a herbal medicine used to treat mild anxiety and depression called St. John’s wort.
If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking Vimpat.
As a safety precaution do not take Vimpat with alcohol.
Fertile women should discuss the use of contraceptives with the doctor.
If you are pregnant or breast-feeding, think you may be pregnant or planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
It is not recommended to take Vimpat if you are pregnant or breast-feeding, as the effects of Vimpat on pregnancy and the unborn baby or the new-born child are not known. Also, it is not known whether Vimpat passes into breast milk. Seek advice immediately from your doctor if you get pregnant or are planning to become pregnant. They will help you decide if you should take Vimpat or not.
Do not stop treatment without talking to your doctor first as this could increase your fits (seizures). A worsening of your disease can also harm your baby.
Do not drive, cycle or use any tools or machines until you know how this medicine affects you. This is
because Vimpat may make you feel dizzy or cause blurred vision.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Other form(s) of this medicine may be more suitable for children; ask your doctor or pharmacist.
Take Vimpat twice each day - approximately 12 hours apart.
Try to take it at about the same time each day.
Swallow the Vimpat tablet with a glass of water.
You may take Vimpat with or without food.
You will usually start by taking a low dose each day and your doctor will slowly increase this over a number of weeks. When you reach the dose that works for you, this is called the “maintenance dose”, you then take the same amount each day. Vimpat is used as a long term treatment. You should continue to take Vimpat until your doctor tells you to stop.
Listed below are the normal recommended doses of Vimpat for different age groups and weights.
Your doctor may prescribe a different dose if you have problems with your kidneys or with your liver.
WhenyoutakeVimpatonitsown
The usual starting dose of Vimpat is 50 mg twice a day.
Your doctor may also prescribe a starting dose of 100 mg of Vimpat twice a day.
Your doctor may increase your twice daily dose every week by 50 mg. This will be until you reach a maintenance dose between 100 mg and 300 mg twice a day.
WhenyoutakeVimpatwithotherantiepilepticmedicines
The usual starting dose of Vimpat is 50 mg twice a day.
Your doctor may increase your twice daily dose every week by 50 mg. This will be until you reach a maintenance dose between 100 mg and 200 mg twice a day.
If you weigh 50 kg or more, your doctor may decide to start Vimpat treatment with a
single “loading” dose of 200 mg. You would then start your ongoing maintenance dose 12 hours later.
In the treatment of partial-onset seizure: Observe that Vimpat is not recommended for children under
2 years of age.
In the treatment of primary generalised tonic-clonic seizures: Observe that Vimpat is not recommended for children under 4 years of age.
The dose depends on their body weight. They usually start treatment with the syrup and only change to tablets if they are able to take tablets and get the correct dose with the different tablet strengths. The doctor will prescribe the formulation that is best suited to them.
If you have taken more Vimpat than you should, contact your doctor immediately. Do not try to drive.
You may experience:
dizziness;
feeling sick (nausea) or being sick (vomiting);
fits (seizures), heart beat problems such a slow, fast or irregular heart beat, coma or a fall in blood pressure with rapid heartbeat and sweating.
If you have missed a dose within the first 6 hours of the scheduled dose, take it as soon as you remember.
If you have missed a dose beyond the first 6 hours of the scheduled dose, do not take the missed tablet anymore. Instead take Vimpat at the next time that you would normally take it.
Do not take a double dose to make up for a forgotten dose.
Do not stop taking Vimpat without talking to your doctor, as your epilepsy may come back again or become worse.
If your doctor decides to stop your treatment with Vimpat, they will tell you how to decrease the dose step by step.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Nervous system side effects such as dizziness may be higher after a single “loading” dose. Talk to your doctor or pharmacist if you get any of the following:
Headache;
Feeling dizzy or sick (nausea);
Double vision (diplopia).
Short jerks of a muscle or group of muscles (myoclonic seizures);
Difficulties in coordinating your movements or walking;
Problems in keeping your balance, shaking (tremor), tingling (paresthesia) or muscle spasms, falling easily and getting bruises;
Troubles with your memory, thinking or finding words, confusion;
Rapid and uncontrollable movements of the eyes (nystagmus), blurred vision;
A spinning sensation (vertigo), feeling drunk;
Being sick (vomiting), dry mouth, constipation, indigestion, excessive gas in the stomach or bowel, diarrhoea;
Decreased feeling or sensitivity, difficulty in articulating words, disturbance in attention;
Noise in the ear such as buzzing, ringing or whistling;
Irritability, trouble sleeping, depression;
Sleepiness, tiredness or weakness (asthenia);
Itching, rash.
Slow heart rate, palpitations, irregular pulse or other changes in the electrical activity of your heart (conduction disorder);
Exaggerated feeling of wellbeing, seeing and/or hearing things which are not there;
Allergic reaction to medicine intake, hives;
Blood tests may show abnormal liver function, liver injury;
Thoughts of harming or killing yourself or attempting suicide: tell your doctor straight away;
Feeling angry or agitated;
Abnormal thinking or losing touch with reality;
Serious allergic reaction which causes swelling of the face, throat, hands, feet, ankles, or lower legs;
Fainting;
Abnormal involuntary movements (dyskinesia).
Abnormal rapid heartbeat (ventricular tachyarrhythmia);
A sore throat, high temperature and getting more infections than usual. Blood tests may show a severe decrease in a specific class of white blood cells (agranulocytosis);
A serious skin reaction which may include a high temperature and other flu-like symptoms, a rash on the face, extended rash, swollen glands (enlarged lymph nodes). Blood tests may show increased levels of liver enzymes and a type of white blood cell (eosinophilia);
A widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens–Johnson syndrome), and a more severe form causing skin peeling in more than 30 % of the body surface (toxic epidermal necrolysis);
Convulsion.
The additional side effects in children were fever (pyrexia), runny nose (nasopharyngitis), sore throat (pharyngitis), eating less than usual (decreased appetite), changes in behaviour, not acting like themselves (abnormal behavior) and lacking in energy (lethargy). Feeling sleepy (somnolence) is a very common side effect in children and may affect more than 1 in 10 children.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet. You can also report side effects directly via thenationalreportingsystem listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is lacosamide.
One tablet of Vimpat 50 mg contains 50 mg lacosamide. One tablet of Vimpat 100 mg contains 100 mg lacosamide. One tablet of Vimpat 150 mg contains 150 mg lacosamide. One tablet of Vimpat 200 mg contains 200 mg lacosamide.
The other ingredients are:
50 mg tablet: red iron oxide (E172), black iron oxide (E172), indigo carmine aluminium lake (E132).
100 mg tablet: yellow iron oxide (E172).
150 mg tablet: yellow iron oxide (E172), red iron oxide (E172), black iron oxide (E172). 200 mg tablet: indigo carmine aluminium lake (E132).
Vimpat 50 mg are pinkish, oval film-coated tablets of approximately 10.4 mm x 4.9 mm with a debossed ‘SP’ on one side and ‘50’ on the other side.
Vimpat 100 mg are dark yellow, oval film-coated tablets of approximately 13.2 mm x 6.1 mm with a debossed ‘SP’ on one side and ‘100’ on the other side.
Vimpat 150 mg are salmon, oval film-coated tablets of approximately 15.1 mm x 7.0 mm with a debossed ‘SP’ on one side and ‘150’ on the other side.
Vimpat 200 mg are blue, oval film-coated tablets of approximately 16.6 mm x 7.8 mm with a debossed ‘SP’ on one side and ‘200’ on the other side.
Vimpat is available in packs of 14, 28, 56, 60, 14 x 1 and 56 x 1 film-coated tablets.
Vimpat 50 mg and Vimpat 100 mg are available in packs of 168 film-coated tablets and Vimpat 150 mg and Vimpat 200 mg are available in multipacks comprising 3 cartons, each containing
56 tablets. The 14 x 1 and 56 x 1 film-coated tablets packs are available as perforated unit dose
PVC/PVDC blisters sealed with an aluminium foil, the 14, 28, 56 and 168 packs are available with standard PVC/PVDC blisters sealed with an aluminium foil, the 60 packs are available in HDPE
bottles with a child-resistant closure. Not all pack sizes may be marketed.
UCB Pharma S.A., Allée de la Recherche 60, B-1070 Bruxelles, Belgium.
UCB Pharma S.A., Chemin du Foriest, B-1420 Braine-l’Alleud, Belgium. or
Aesica Pharmaceuticals GmbH, Alfred-Nobel Strasse 10, D-40789 Monheim am Rhein, Germany.
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
UCB Pharma SA/NV
Tél/Tel: + 32 / (0)2 559 92 00
UCB Pharma Oy Finland
Tel: + 358 9 2514 4221 (Suomija)
Ю СИ БИ България ЕООД
Teл.: + 359 (0) 2 962 30 49
UCB Pharma SA/NV
Tél/Tel: + 32 / (0)2 559 92 00
UCB s.r.o.
Tel: + 420 221 773 411
UCB Magyarország Kft. Tel.: + 36-(1) 391 0060
UCB Nordic A/S
Tlf: + 45 / 32 46 24 00
Pharmasud Ltd.
Tel: + 356 / 21 37 64 36
UCB Pharma GmbH
Tel: + 49 /(0) 2173 48 4848
UCB Pharma B.V.
Tel.: + 31 / (0)76-573 11 40
UCB Pharma Oy Finland
Tel: + 358 9 2514 4221 (Soome)
UCB Nordic A/S
Tlf: + 45 / 32 46 24 00
UCB Α.Ε.
Τηλ: + 30 / 2109974000
UCB Pharma GmbH
Tel: + 43 (0)1 291 80 00
UCB Pharma, S.A.
Tel: + 34 / 91 570 34 44
UCB Pharma Sp. z o.o. Tel: + 48 22 696 99 20
UCB Pharma S.A.
Tél: + 33 / (0)1 47 29 44 35
Bial – Portela & Cª, S.A. Tel: + 351 22 986 6100
Medis Adria d.o.o.
Tel: +385 (0) 1 230 34 46
UCB Pharma Romania S.R.L.
Tel: + 40 21 300 29 04
UCB (Pharma) Ireland Ltd. Tel: + 353 / (0)1-46 37 395
Medis, d.o.o.
Tel: + 386 1 589 69 00
Vistor hf.
Simi: + 354 535 7000
UCB s.r.o., organizačná zložka
Tel: + 421 (0) 2 5920 2020
UCB Pharma S.p.A.
Tel: + 39 / 02 300 791
UCB Pharma Oy Finland
Puh/Tel: + 358 9 2514 4221
Lifepharma (Z.A.M.) Ltd Τηλ: + 357 22 05 63 00
UCB Nordic A/S
Tel: + 46 / (0) 40 29 49 00
UCB Pharma Oy Finland
Tel: + 358 9 2514 4221 (Somija)
UCB (Pharma) Ltd.
Tel: + 353 / (0)1-46 37 395